Tumor lysis syndrome (TLS) is a potentially life-threatening metabolic disorder characterized by an elevated uric acid level, elevated serum potassium and phosphorus levels, and a decreased calcium level.
Jeanne Held-warmkessel, MSN
Advertisement
Articles by Jeanne Held-warmkessel, MSN
Advertisement
Latest Updated Articles
A Patient With Tumor Lysis SyndromeAugust 27th 2012
Advertisement
Advertisement
Trending on CancerNetwork
1
FDA Approves Vepdegestrant in ER+, HER2–, ESR1-Mutated Breast Cancer
2
FDA Permits Expanded Daraxonrasib Access in Previously Treated Metastatic PDAC
3
FDA ODAC Votes Yes to Capivasertib for PTEN-Deficient Metastatic HSPC
4
Targeting KRAS in Pancreatic Cancer: What Is Daraxonrasib’s Mechanism of Action?
5